KP Tissue Inc. (KPTSF)
USD 5.68
(0.0%)
USD 5.68
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 6.98 Million | -10.32 Million | 1.15 Million | -2.44 Million | -6.91 Million | -369 Thousand |
| Net Income | -4.93 Million | -10.24 Million | 1.23 Million | -1.95 Million | -6.52 Million | -173 Thousand |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | 4.1 Million | -1.88 Million | -2.2 Million | -1.42 Million | 720 Thousand | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 287 Thousand | -76 Thousand | 233 Thousand | 146 Thousand | 189 Thousand | -269.00 |
| Other non-cash items | 7.52 Million | 1.88 Million | 1.88 Million | 786 Thousand | -1.29 Million | 173 Thousand |
| Investing Cash Flow | 6.98 Million | 6.61 Million | 5.56 Million | 5.59 Million | 4.98 Million | 4.64 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | 5.56 Million | 5.59 Million | 4.98 Million | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 6.98 Million | 6.61 Million | 5560.00 | 5595.00 | 4.98 Million | 4.64 Million |
| Financing Cash Flow | -6.98 Million | -6.61 Million | -5.56 Million | -5.59 Million | -4.98 Million | -4.64 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -6.98 Million | -6.61 Million | -5.56 Million | -5.59 Million | -4984.00 | -4640.00 |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | 2.06 Million | 874 Thousand | 22 Thousand | -269.00 |
| Accounts payables | 287 Thousand | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 287 Thousand | -76 Thousand | -1.83 Million | -728 Thousand | -22 Thousand | - |
| Cash at beginning of period | - | - | - | - | - | - |
| Cash at end of period | 6.98 Million | -10.32 Million | 1.15 Million | -2.44 Million | -6.91 Million | -369 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 6.98 Million | -10.32 Million | 1.15 Million | -2.44 Million | -6.91 Million | -369 Thousand |
| Free Cash Flow | 6.98 Million | -10.32 Million | 1.15 Million | -2.44 Million | -6.91 Million | -369 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.19 Million | 1.13 Million | -4.93 Million | 1.96 Million | 1.76 Million | 2.01 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | 4.1 Million | 215 Thousand | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -200 Thousand | -84 Thousand | 287 Thousand | 424 Thousand | -137 Thousand | - |
| Other non-cash items | 752 Thousand | 705 Thousand | 7.52 Million | -860 Thousand | -1.62 Million | -2.01 Million |
| Investing Cash Flow | 1.74 Million | 1.75 Million | 6.98 Million | 1.74 Million | 1.73 Million | 1.76 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 1.74 Million | 1752.00 | 6.98 Million | 1.74 Million | 1.73 Million | 1.76 Million |
| Financing Cash Flow | -1.74 Million | -1.75 Million | -6.98 Million | -1.74 Million | -1.73 Million | -1.76 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | -1.74 Million | -1.75 Million | -6.98 Million | -1.74 Million | -1.73 Million | -1.76 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | 287 Thousand | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -200 Thousand | -84 Thousand | - | 424 Thousand | - | - |
| Cash at beginning of period | - | - | - | - | - | - |
| Cash at end of period | 1.74 Million | 1.75 Million | 6.98 Million | 1.74 Million | 1.36 Million | 2.01 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 1.74 Million | 1.75 Million | 6.98 Million | 1.74 Million | 1.36 Million | 2.01 Million |
| Free Cash Flow | 1.74 Million | 1.75 Million | 6.98 Million | 1.74 Million | 1.36 Million | 2.01 Million |
LABFF
KALAMANDIR
TM
IESC
LGBBROSLTD
VERX